Parnax Lab Limited (PARNAXLAB) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE383L01019
Key metrics
- Market Cap
- ₹160 Cr
- P/E Ratio
- 17.9
- EPS
- 7.79
- Book Value
- 82.97
- P/B Ratio
- 1.68
- ROE
- 12.36%
- ROCE
- 10.78%
- Debt / Equity
- 0.87
- Net Margin
- 4.74%
- Revenue Growth
- 32.39%
- Profit Growth
- 2.24%
- Dividend Yield
- —
- 52W High
- ₹182.00
- 52W Low
- ₹99.20
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Parnax Lab Limited
Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally. The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic products; herbal products; and nutraceutical products. It also provides Oral Formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, formulations for geriatrics, highly viscous products, and suspensions. In addition, the company provides drug identification and development services; in- and out-licensing services; and contract research and manufacturing services The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012. The company was incorporated in 1982 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Promoter Holding
- 85.34%
The full Parnax Lab Limited analysis
Create a free account to open the complete PARNAXLAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.